To examine the ubiquity of the integral role of p21 as a cyclin-dependent kinase inhibitor, two other human pancreatic cancer cell lines were examined: PANC-1 and Capan-2. This evidence concerns the gene CDKN3 and familial pancreatic carcinoma.